Biomedical Science Letters

eISSN 2288-7415

Download original image
Fig. 2.

Effects of scopoletin on platelet aggregation. (A) Concentration threshold of U46619 on human platelet aggregation. (B) Effects of scopoletin on platelet aggregation stimulated by U46619. (C) Half-maximal inhibitory concentration (IC50) value of scopoletin in U46619-stimulated human platelet aggregation. Data are expressed as means ± SD (n=4). *P<0.05, **P<0.001 compared with the U46619-stimulated platelets.

Biomed Sci Letters 2019;25:123-30 https://doi.org/10.15616/BSL.2019.25.2.123
© 2019 Biomed Sci Letters